Publications

Yadong Huang, MD, PhDGenetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. View in: PubMed
Yadong Huang, MD, PhDAssmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996 Jul; 124 Suppl:S11-20. View in: PubMed
Yadong Huang, MD, PhDEffects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice. View in: PubMed
Yadong Huang, MD, PhDApolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. View in: PubMed
Yadong Huang, MD, PhDvon Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assmann G. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta. 1996 Jun 11; 1301(3):255-62. View in: PubMed
Yadong Huang, MD, PhDA natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma. View in: PubMed
Yadong Huang, MD, PhDvon Eckardstein A, Huang Y, Wu S, Assmann G. Uptake, transfer, and esterification of cell-derived cholesterol in plasma of patients with familial HDL-deficiency. Z Gastroenterol. 1996 Jun; 34 Suppl 3:143-4. View in: PubMed
Yadong Huang, MD, PhDHypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. View in: PubMed
Yadong Huang, MD, PhDHuang Y, von Eckardstein A, Wu S, Assmann G. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J Clin Invest. 1995 Dec; 96(6):2693-701. View in: PubMed
Yadong Huang, MD, PhDHigh-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. View in: PubMed